Surveillance: Eli Lilly CEO Sees Brighter Future

David Ricks, Eli Lilly Chairman & CEO, discusses the drugmaker’s Covid-19 antibody therapy that was granted emergency-use authorization in the U.S. Subadra Rajappa, Societe Generale Head of U.S. Rates Strategy, sees a departure from bonds into risky assets with a lot of cash on the sidelines that needs to be put to work. Kathy Hochul, New York Lieutenant Governor, says having a vaccine does not take the pressure off of further stimulus at all. Sam Stovall, CFRA Chief Investment Strategist, says Wall Street is looking beyond a coronavirus spike with vaccine developments appearing positive.

See omnystudio.com/listener for privacy information.